On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
60° Feels Like: 60°
Wind: WNW 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 84°

Tonight

Isolated Thunderstorms 55°

Tomorrow

Few Showers 69°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

FDA lifts hold on studies testing Cell Therapeutics' cancer drug

(Reuters) - Cell Therapeutics Inc said the U.S. Food and Drug Administration lifted a hold imposed in June last year on studies testing the company's blood cancer drug.

The company's shares rose about 3 percent to $1.97 in premarket trading on Thursday.

Cell Therapeutics said it received the notification from the regulator on December 26.

The FDA placed the hold after a patient treated with a combination of the drug, tosedostat, and a chemotherapy drug died of a heart muscle infection.

Under the hold, the company could not enroll new patients in any trials of tosedostat.

The regulator asked for more information on all heart-related events in patients treated with the drug.

Tosedostat is being tested in mid-stage trials in the United States and European Union on elderly patients with two forms of blood cancer - acute myeloid leukemia and myelodysplastic syndrome.

(Reporting by Vrinda Manocha in Bangalore; Editing by Kirti Pandey)

Comments